Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

1.

The role of CD81 for plasma cell dyscrasias.

Binder M, Bacher U.

Leuk Res. 2014 Mar;38(3):292-3. doi: 10.1016/j.leukres.2013.12.026. Epub 2014 Jan 9. No abstract available.

PMID:
24462475
[PubMed - indexed for MEDLINE]
2.

Flow cytometric differentiation of abnormal and normal plasma cells in the bone marrow in patients with multiple myeloma and its precursor diseases.

Tembhare PR, Yuan CM, Venzon D, Braylan R, Korde N, Manasanch E, Zuchlinsky D, Calvo K, Kurlander R, Bhutani M, Tageja N, Maric I, Mulquin M, Roschewski M, Kwok M, Liewehr D, Landgren O, Stetler-Stevenson M.

Leuk Res. 2014 Mar;38(3):371-6. doi: 10.1016/j.leukres.2013.12.007. Epub 2013 Dec 11.

PMID:
24462038
[PubMed - indexed for MEDLINE]
3.

[Monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma].

Schleiffenbaum BE.

Praxis (Bern 1994). 2012 Nov 28;101(24):1521-9; quiz 1530-1. doi: 10.1024/1661-8157/a001137. German. No abstract available.

PMID:
23184544
[PubMed - indexed for MEDLINE]
4.

Bone-marrow immunophenotypic analysis allows the identification of high risk of progression and immune condition-related monoclonal gammopathy of undetermined significance.

Jerez A, Ortuño FJ, Osma Mdel M, Español I, González AD, Roldán V, de Arriba F, Vicente V.

Ann Med. 2009;41(7):547-58. doi: 10.1080/07853890903111000.

PMID:
19634064
[PubMed - indexed for MEDLINE]
5.

Bone-marrow plasmocytosis--an immunohistological study.

Eckert F, Schmid L, Kradolfer D, Schmid U.

Blut. 1986 Jul;53(1):11-9.

PMID:
3719110
[PubMed - indexed for MEDLINE]
6.

Advances in the diagnosis and management of myeloma.

Greipp PR.

Semin Hematol. 1992 Jul;29(3 Suppl 2):24-45. Review. No abstract available.

PMID:
1509293
[PubMed - indexed for MEDLINE]
7.

Multiple myeloma arising from monoclonal gammopathy of undetermined significance in a patient with Gaucher's disease.

Brady K, Corash L, Bhargava V.

Arch Pathol Lab Med. 1997 Oct;121(10):1108-11.

PMID:
9341594
[PubMed - indexed for MEDLINE]
8.
9.

[Management in paraproteinemia].

Sonneveld P, Löwenberg B.

Ned Tijdschr Geneeskd. 1992 Feb 22;136(8):384-5. Dutch. No abstract available.

PMID:
1538819
[PubMed - indexed for MEDLINE]
10.

Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.

Kyle RA.

Eur J Haematol Suppl. 1989;51:70-5.

PMID:
2516809
[PubMed - indexed for MEDLINE]
11.

Monoclonal gammopathy of undetermined significance: a new proposal of workup.

Mangiacavalli S, Cocito F, Pochintesta L, Pascutto C, Ferretti V, Varettoni M, Zappasodi P, Pompa A, Landini B, Cazzola M, Corso A.

Eur J Haematol. 2013 Oct;91(4):356-60. doi: 10.1111/ejh.12172. Epub 2013 Aug 17.

PMID:
23859528
[PubMed - indexed for MEDLINE]
12.

Monoclonal gammopathy and smoldering multiple myeloma: diagnosis, staging, prognosis, management.

Hillengass J, Moehler T, Hundemer M.

Recent Results Cancer Res. 2011;183:113-31. doi: 10.1007/978-3-540-85772-3_6. Review.

PMID:
21509683
[PubMed - indexed for MEDLINE]
13.

Phenotype of plasma cells in multiple myeloma and monoclonal gammopathy of undetermined significance.

Kovarova L, Buresova I, Buchler T, Suska R, Pour L, Zahradova L, Penka M, Hajek R.

Neoplasma. 2009;56(6):526-32.

PMID:
19728762
[PubMed - indexed for MEDLINE]
14.

Differentiation of monoclonal gammopathy of undetermined significance and multiple myeloma using flow cytometric characteristics of plasma cells.

Sezer O, Heider U, Zavrski I, Possinger K.

Haematologica. 2001 Aug;86(8):837-43.

PMID:
11522540
[PubMed - indexed for MEDLINE]
Free Article
15.

Does my patient with a serum monoclonal spike have multiple myeloma?

Bianchi G, Ghobrial IM.

Hematol Oncol Clin North Am. 2012 Apr;26(2):383-93, ix. doi: 10.1016/j.hoc.2012.02.009. Review.

PMID:
22463833
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Use of cytoplasmic 5'nucleotidase for differentiating malignant from benign monoclonal gammopathies.

Majumdar G, Heard SE, Singh AK.

J Clin Pathol. 1990 Nov;43(11):891-2.

PMID:
2262558
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

A multiparameter flow cytometry immunophenotypic algorithm for the identification of newly diagnosed symptomatic myeloma with an MGUS-like signature and long-term disease control.

Paiva B, Vídriales MB, Rosiñol L, Martínez-López J, Mateos MV, Ocio EM, Montalbán MÁ, Cordón L, Gutiérrez NC, Corchete L, Oriol A, Terol MJ, Echeveste MA, De Paz R, De Arriba F, Palomera L, de la Rubia J, Díaz-Mediavilla J, Granell M, Gorosquieta A, Alegre A, Orfao A, Lahuerta JJ, Bladé J, San Miguel JF; Grupo Español de MM/Programa para el Estudio de la Terapéutica en Hemopatías Malignas Cooperative Study Group.

Leukemia. 2013 Oct;27(10):2056-61. doi: 10.1038/leu.2013.166. Epub 2013 Jun 7. Erratum in: Leukemia. 2013 Oct;27(10):2112.

PMID:
23743858
[PubMed - indexed for MEDLINE]
18.

Role of flow cytometry of peripheral blood and bone marrow aspirates in early myeloma.

Yuan CM, Stetler-Stevenson M.

Semin Hematol. 2011 Jan;48(1):32-8. doi: 10.1053/j.seminhematol.2010.11.005. Review.

PMID:
21232656
[PubMed - indexed for MEDLINE]
19.

Diagnosis and management of multiple myeloma and related disorders.

Kyle RA.

Prog Hematol. 1986;14:257-82. Review. No abstract available.

PMID:
2418463
[PubMed - indexed for MEDLINE]
20.

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk